These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7932411)

  • 41. Anti-Ro antibodies in rheumatoid arthritis.
    Zanlorenzi L; Azevedo Pde O; Silva MB; Skare T
    Acta Reumatol Port; 2012; 37(2):149-52. PubMed ID: 23149637
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of anti-Ro(SSA) antibody in rheumatoid arthritis.
    Boire G; Ménard HA
    J Rheumatol; 1988 Mar; 15(3):391-4. PubMed ID: 3259983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rheumatoid factors in Ro (SSA) positive and Ro (SSA) negative rheumatoid arthritis patients.
    Gharavi AE; Skopouli FN; Patel BM; Hughes GR; Moutsopoulos HM
    Rheumatol Int; 1986; 6(2):61-2. PubMed ID: 3489974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to Ro/SSA detected by ELISA: correlation with clinical features in systemic scleroderma.
    Bell S; Krieg T; Meurer M
    Br J Dermatol; 1989 Jul; 121(1):35-41. PubMed ID: 2788010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance of anti-Ro antibodies in rheumatoid arthritis.
    Schneeberger E; Citera G; Heredia M; Maldonado Cocco J
    Clin Rheumatol; 2008 Apr; 27(4):517-9. PubMed ID: 18183345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of gold-reactive T lymphocytes in rheumatoid arthritis patients treated with gold.
    Verwilghen J; Kingsley GH; Gambling L; Panayi GS
    Arthritis Rheum; 1992 Dec; 35(12):1413-8. PubMed ID: 1472120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antiglobulin factors in rheumatoid arthritis--etiological significance and fluctuation by gold therapy (author's transl)].
    Ohara A; Ezawa H; Ofuji T
    Ryumachi; 1977 Jul; 17(4):381-7. PubMed ID: 302990
    [No Abstract]   [Full Text] [Related]  

  • 48. [A case of anti-RNP antibody positive malignant rheumatoid arthritis with pulmonary hypertension].
    Tsuji M; Dowaki M; Yamada A; Nakura Y; Takahashi S; Hatano M; Sawada S; Nishinarita S; Ishikawa H
    Nihon Naika Gakkai Zasshi; 1991 Oct; 80(10):1673-5. PubMed ID: 1774534
    [No Abstract]   [Full Text] [Related]  

  • 49. Serum IgA levels and ANA behaviour in rheumatoid patients with and without toxicity to remission-inducing drugs.
    Ferraccioli GF; Nervetti A; Mercadanti M; Cavalieri F
    Clin Exp Rheumatol; 1986; 4(3):217-20. PubMed ID: 2945684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic destructive monoarthritis of the wrist in patients with anti-SSA/Ro antibodies: report of two cases.
    Satoh M; Yamagata H; Watanabe F; Matsushita Y; Nakayama S; Okubo K; Akizuki M
    Clin Rheumatol; 1993 Jun; 12(2):274-7. PubMed ID: 8358994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rheumatoid arthritis in a United States Public Health Service Hospital in Oklahoma: serologic manifestations in rheumatoid arthritis vary among tribal groups.
    Scofield RH; Fogle M; Rhoades ER; Harley JB
    Arthritis Rheum; 1996 Feb; 39(2):283-6. PubMed ID: 8849380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Concept and management of specific physiopathology of collagen diseases. 1) Approach to healthy individuals with positive anti-nuclear antibody reactions].
    Abe T
    Nihon Naika Gakkai Zasshi; 1997 Aug; 86(8):1381-4. PubMed ID: 9410940
    [No Abstract]   [Full Text] [Related]  

  • 53. [Malignant rheumatoid arthritis and antinuclear antibodies].
    Honma M; Komeji A; Tojo T; Tominaga N; Akizuki S
    Nihon Rinsho; 1976 Jan; 34(1):207-11. PubMed ID: 1082522
    [No Abstract]   [Full Text] [Related]  

  • 54. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study.
    Drosos AA; Lanchbury JS; Panayi GS; Moutsopoulos HM
    Arthritis Rheum; 1992 Jul; 35(7):745-8. PubMed ID: 1622412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of antinuclear antibodies in patients with rheumatoid arthritis receiving treatment with human recombinant interferon gamma.
    Seitz M; Franke M; Kirchner H
    Ann Rheum Dis; 1988 Aug; 47(8):642-4. PubMed ID: 3137901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Undesirable effects of gold salts.
    Davis P
    J Rheumatol Suppl; 1979; 5():18-24. PubMed ID: 290813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum IgA and gold toxicity in rheumatoid arthritis: lack of predicting value.
    Ostuni PA; Simioni M; Marson P; Travaglia P; Volante D; Gambari PF
    Clin Exp Rheumatol; 1986; 4(4):359-62. PubMed ID: 3791719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum IgE concentrations in rheumatoid arthritis: lack of correlation with gold toxicity.
    Grennan DM; Palmer DG
    Br Med J; 1979 Dec; 2(6203):1477-8. PubMed ID: 526817
    [No Abstract]   [Full Text] [Related]  

  • 59. [Research of rheumatoid arthritis 36 kD antibody].
    Jiang M
    Zhonghua Nei Ke Za Zhi; 1994 Apr; 33(4):223. PubMed ID: 7956559
    [No Abstract]   [Full Text] [Related]  

  • 60. [Alveolitis--a rare side effect of gold therapy].
    Liebetrau G
    Z Erkr Atmungsorgane; 1984; 163(2):200-4. PubMed ID: 6506808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.